Optimizing Perioperative Pain Management: An Evidence-Based Approach
Pain management requires a multidisciplinary approach and should be part of an overall care plan to enhance patient outcomes. These education modules expose surgeons and their patient care teams to a complete package of perioperative pain management to achieve better outcomes, reduce opioid misuse and increase patient satisfaction. Surgical specialists manage acute pain in each surgical intervention, which include preoperative, intraoperative, and postoperative periods, as well as pain management at the end of life. All of these topics are featured in this learning program.
The program consists of eight e-learning modules designed to be taken in sequence. Each module is case-based and contains a minimum of three multiple choice questions (MCQs) interspersed throughout the content to engage the learner throughout each presentation.
- Module 1: Understanding the Mechanisms of Pain
- Module 2: Risks of Perioperative Opioids
- Module 3: Expectation Setting
- Module 4: Multimodal Pain Therapy
- Module 5: Outpatient Postoperative Opioid Prescribing
- Module 6: Pre-Existing Opioid Use
- Module 7: Substance Misuse History
- Module 8: Pain Management at the End-of-Life: Final Hours to Days
- Practicing surgeons
After completing Optimizing Pain Management: An Evidence-Based Approach, learners will be able to:
- Outline the array of pain management approaches essential for effective surgical care, including multimodal therapies and pain management with and without the use of opioids.
- Describe differences in appropriate pain management approaches for straightforward and complex patient profiles across preoperative, intraoperative, postoperative, and end-of-life periods.
- Discuss the implications of opioid use in perioperative patients and the strategies to manage patients with profiles ranging from opioid naïve, to opioid use for chronic pain, and to opioid dependency.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Faculty and Disclosures
Bridget N. Fahy, MD, FACS - AbioMed Inc., Amgen Inc., Natus Med Inc. Del, Becton Dickinson & Com, Biomarin Pharmaceuticals, Celgene Corp, Ecolab, Editas Medicine Inc., Guardant Health Inc., Gilead Sciences Inc., Chart Inds Inc., HCA Healthcare Inc., Health Equity, Hill Rom HLDGS, Idexx Lab Inc. Del, Illumina Inc., Intuitive Surgical Inc., Masimo, Novocure, Insulet Corp. Com, Resmed Inc., Shockwave Medical Inc., Teladoc Health Inc. Com, UnitedHealth Group, Vertex Pharmaceuticals Inc.
David J. Herrmann, PharmD, BCCCP - Nothing to disclose
Paul E. Hilliard, MS, MD - Nothing to disclose
David A. Kooby, MD, FACS - Nothing to disclose
Carolyn Lefkowits, MD, MPH, MS - Nothing to disclose
Lena M. Napolitano, MD, FACS, FCCP, MCCM - Nothing to disclose
Richard W. Rosenquist, MD - UpToDate Inc., Oxford University Press, Mainstay Medical, Kure Pain Holdings, LLC
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME - Nothing to disclose
Travis P. Webb, MD, MHPE, FACS - Nothing to disclose
John A. Weigelt, MD, FACS - Nothing to disclose
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Self Assessment Credit
- 8.00 Certificate of Completion